Spain
· Delayed Price · Currency is EUR Natac Natural Ingredients Statistics
Total Valuation
BME:NAT has a market cap or net worth of EUR 304.37 million.
| Market Cap | 304.37M |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Monday, May 5, 2025.
| Earnings Date | May 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:NAT has 434.81 million shares outstanding.
| Current Share Class | 434.81M |
| Shares Outstanding | 434.81M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -28.05% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.22% |
| Float | n/a |
Valuation Ratios
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | 70.00 |
| PS Ratio | 274.37 |
| PB Ratio | 7.44 |
| P/TBV Ratio | 340.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.88, with a Debt / Equity ratio of 0.10.
| Current Ratio | 4.88 |
| Quick Ratio | 4.48 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.45 |
| Interest Coverage | -1.82 |
Financial Efficiency
Return on equity (ROE) is -2.59% and return on invested capital (ROIC) is -2.50%.
| Return on Equity (ROE) | -2.59% |
| Return on Assets (ROA) | -2.12% |
| Return on Invested Capital (ROIC) | -2.50% |
| Return on Capital Employed (ROCE) | -3.03% |
| Revenue Per Employee | 65,256 |
| Profits Per Employee | -36,565 |
| Employee Count | 17 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 6.93 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.65% in the last 52 weeks. The beta is -0.44, so BME:NAT's price volatility has been lower than the market average.
| Beta (5Y) | -0.44 |
| 52-Week Price Change | +17.65% |
| 50-Day Moving Average | 0.63 |
| 200-Day Moving Average | 0.64 |
| Relative Strength Index (RSI) | 69.69 |
| Average Volume (20 Days) | 106,210 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:NAT had revenue of EUR 1.11 million and -621,613 in losses. Loss per share was -0.02.
| Revenue | 1.11M |
| Gross Profit | 750,618 |
| Operating Income | -1.65M |
| Pretax Income | -2.31M |
| Net Income | -621,613 |
| EBITDA | -1.62M |
| EBIT | -1.65M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 4.93 million in cash and 4.19 million in debt, giving a net cash position of 742,474 or 0.00 per share.
| Cash & Cash Equivalents | 4.93M |
| Total Debt | 4.19M |
| Net Cash | 742,474 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 40.90M |
| Book Value Per Share | 1.02 |
| Working Capital | 4.98M |
Cash Flow
In the last 12 months, operating cash flow was -4.94 million and capital expenditures -4.31 million, giving a free cash flow of -9.24 million.
| Operating Cash Flow | -4.94M |
| Capital Expenditures | -4.31M |
| Free Cash Flow | -9.24M |
| FCF Per Share | -0.02 |
Margins
Gross margin is 67.66%, with operating and profit margins of -148.42% and -56.03%.
| Gross Margin | 67.66% |
| Operating Margin | -148.42% |
| Pretax Margin | -208.50% |
| Profit Margin | -56.03% |
| EBITDA Margin | -145.83% |
| EBIT Margin | -148.42% |
| FCF Margin | n/a |
Dividends & Yields
BME:NAT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -64.39% |
| Shareholder Yield | -64.39% |
| Earnings Yield | -0.20% |
| FCF Yield | -3.04% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |